{
    "nct_id": "NCT05664711",
    "official_title": "Effect of Stellate Ganglion Block on ME/CFS Symptoms and Metabolites",
    "inclusion_criteria": "* Age (18-50 years)\n* Female\n* ME/CFS (CCC and IOM criteria) duration less than 4 years at time of study enrollment\n* Confirmed or suspected viral disease prior to ME/CFS onset (e.g., SARS-CoV-2, Epstein-Barr, Influenza)\n* BMI =18-29 kg/m^2\n* Ability to read, write and speak English language\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 50 Years",
    "exclusion_criteria": "* Prior SGB treatment\n* Allergy to amide local anesthetics (e.g. ropivacaine, bupivacaine)\n* Current anticoagulant use\n* History of bleeding disorder\n* History of glaucoma\n* Infection or mass at injection site\n* Anatomical abnormalities in C3-T1 region\n* Current pregnancy\n* Hypertension\n* Diabetes (any type)\n* Thyroid disease\n* History of neck or throat surgeries\n* Vocal cord problems or paralysis\n* Causalgia/Chronic Regional Pain Syndrome (CRPS)\n* Current cancer diagnosis\n* Diagnosis of Guillain-Barr√© syndrome\n* Diagnosis of current moderate or severe substance use disorder\n* History of neurological disease, seizure, or significant head trauma\n* Conditions or disorders (other than ME/CFS) that affect cognitive functioning including stroke, past or present diagnosis of psychosis or psychotic symptoms, diagnosis of bipolar I disorder, or severe depression",
    "miscellaneous_criteria": ""
}